ALR Technologies SG (ALRTF) Net Income towards Common Stockholders (2022 - 2025)

ALR Technologies SG (ALRTF) posted Net Income towards Common Stockholders of -$620706.0 for Q2 2025, up 23.68% on a QoQ basis from -$813331.0 in Q2 2024, and up 23.68% year-over-year from -$501850.4 in Q2 2024.

ALR Technologies SG (ALRTF) Net Income towards Common Stockholders (2022 - 2025) Analysis & Trends

ALR Technologies SG's Net Income towards Common Stockholders history runs 4 years deep, the most recent figure standing at -$620706.0 for Q2 2025.

  • Quarterly Net Income towards Common Stockholders rose 23.68% year-over-year to -$620706.0 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was -$1.4 million (up 31.04% YoY) and the FY2025 annual result came in at -$2.9 million, up 15.55% from the prior year.
  • Net Income towards Common Stockholders was -$620706.0 for Q2 2025 at ALR Technologies SG, up from -$813331.0 in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$620706.0 in Q2 2025 and bottomed at -$1.3 million in Q2 2023.
  • A 4-year average of -$907183.0 and a median of -$870984.5 in 2022 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders slumped 36.33% — and 2024, when it jumped 35.76%.
  • ALR Technologies SG's Net Income towards Common Stockholders stood at -$928638.0 in 2022, then tumbled by 36.33% to -$1.3 million in 2023, then jumped by 35.76% to -$813331.0 in 2024, then increased by 23.68% to -$620706.0 in 2025.
  • Business Quant data shows ALRTF's Net Income towards Common Stockholders at -$620706.0 in Q2 2025, -$813331.0 in Q2 2024, and -$1.3 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 1.08 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 745.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 176.78 Mn
10 ALR Technologies SG 61.20 Mn 61.18 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -620,706.00
Jun 30, 2024 -813,331.00
Jun 30, 2023 -1.27 Mn
Jun 30, 2022 -928,638.00